|
|
|
|
Searching in 'World-2DPAGE Repository [0019]' for entry matching: P63261 |
World-2DPAGE Repository (0019): P63261
P63261:
Nice View - a user-friendly view of this entry
ID ACTG_HUMAN;
AC P63261;
DT 09-Dec-2009, integrated into Rat hippocampal synaptoproteome (release 1).
DT 30-May-2011, 2D annotation version 2.
DT 13-Jan-2012, general annotation version 2.
DE RecName: Full=Actin, cytoplasmic 2; AltName: Full=Gamma-actin; Contains:
DE RecName: Full=Actin, cytoplasmic 2, N-terminally processed;.
GN Name=ACTG1; Synonyms=ACTB, ACTG;
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC Muroidea; Muridae; Murinae; Rattus.
OX NCBI_TaxID=10116;
IM HIPP_SYNAP.
RN [1]
RP 2D-PAGE GEL CHARACTERIZATION.
RX DOI=10.1111/j.1471-4159.2010.06719.x;
RA VanGuilder H.D., Yan H., Farley J.A., Sonntag W.E., Freeman W.M.;
RT ''Aging alters the expression of neurotransmission-regulating proteins in
RT the hippocampal synaptoproteome'';
RL J of Neurochemistry 113(6):1577-1588 (2010).
2D -!- MASTER: HIPP_SYNAP;
2D -!- PI/MW: SPOT 548=5.31/42107;
2D -!- PI/MW: SPOT 552=5.31/42107;
2D -!- PI/MW: SPOT 568=5.31/42107;
2D -!- PI/MW: SPOT 570=5.31/42107;
2D -!- PI/MW: SPOT 711=5.31/42107;
2D -!- PI/MW: SPOT 718=5.31/42107;
2D -!- PI/MW: SPOT 779=5.31/42107;
2D -!- PI/MW: SPOT 801=5.31/42107;
2D -!- PI/MW: SPOT 804=5.31/42107;
2D -!- PI/MW: SPOT 818=5.31/42107;
2D -!- PI/MW: SPOT 821=5.31/42107;
2D -!- PI/MW: SPOT 845=5.31/42107;
2D -!- PI/MW: SPOT 846=5.31/42107;
2D -!- PI/MW: SPOT 1003=5.31/42107;
2D -!- PI/MW: SPOT 1066=5.31/42107;
2D -!- PI/MW: SPOT 1076=5.31/42107;
2D -!- PI/MW: SPOT 1078=5.31/42107;
2D -!- PI/MW: SPOT 1116=5.31/42107;
2D -!- IDENTIFICATION: SPOT 548: Peptides number=8. SeqCov=33.3%. MOWSE
2D score=4.88E+13 [1]; SPOT 552: Peptides number=5. SeqCov=21.1%. MOWSE
2D score=1.77E+7 [1]; SPOT 568: Peptides number=6. SeqCov=23.5%. MOWSE
2D score=1.47E+7 [1]; SPOT 570: Peptides number=8. SeqCov=32.8%. MOWSE
2D score=1.46E+6 [1]; SPOT 711: Peptides number=7. SeqCov=33.9%. MOWSE
2D score=4.10E+11 [1]; SPOT 718: Peptides number=5. SeqCov=24%. MOWSE
2D score=4.75E+6 [1]; SPOT 779: Peptides number=5. SeqCov=24%. MOWSE
2D score=4.75E+6 [1]; SPOT 801: Peptides number=8. SeqCov=27.7%. MOWSE
2D score=8.47E+6 [1]; SPOT 804: Peptides number=3. SeqCov=13.6%. MOWSE
2D score=8.80E+4 [1]; SPOT 818: Peptides number=3. SeqCov=15.7%. MOWSE
2D score=4.10E+3 [1]; SPOT 821: Peptides number=3. SeqCov=13.6%. MOWSE
2D score=5.78E+4 [1]; SPOT 845: Peptides number=3. SeqCov=12.5%. MOWSE
2D score=3.79E+3 [1]; SPOT 846: Peptides number=4. SeqCov=18.4%. MOWSE
2D score=1.18E+4 [1]; SPOT 1003: Peptides number=6. SeqCov=22.9%. MOWSE
2D score=6.61E+5 [1]; SPOT 1066: Peptides number=7. SeqCov=38.4%. MOWSE
2D score=1.06E+10 [1]; SPOT 1076: Peptides number=6. SeqCov=32%. MOWSE
2D score=1.06E+10 [1]; SPOT 1078: Peptides number=4. SeqCov=17.1%. MOWSE
2D score=1.23E+4 [1]; SPOT 1116: Peptides number=7. SeqCov=40%. MOWSE
2D score=6.41E+9 [1].
2D -!- MAPPING: SPOT 548: Peptide mass fingerprinting [1]; SPOT 548:
2D Tandem mass spectrometry [1]; SPOT 552: Peptide mass fingerprinting [1];
2D SPOT 552: Tandem mass spectrometry [1]; SPOT 568: Peptide mass
2D fingerprinting [1]; SPOT 568: Tandem mass spectrometry [1]; SPOT 570:
2D Peptide mass fingerprinting [1]; SPOT 570: Tandem mass spectrometry [1];
2D SPOT 711: Peptide mass fingerprinting [1]; SPOT 711: Tandem mass
2D spectrometry [1]; SPOT 718: Peptide mass fingerprinting [1]; SPOT 718:
2D Tandem mass spectrometry [1]; SPOT 779: Peptide mass fingerprinting [1];
2D SPOT 779: Tandem mass spectrometry [1]; SPOT 801: Peptide mass
2D fingerprinting [1]; SPOT 801: Tandem mass spectrometry [1]; SPOT 804:
2D Peptide mass fingerprinting [1]; SPOT 804: Tandem mass spectrometry [1];
2D SPOT 818: Peptide mass fingerprinting [1]; SPOT 818: Tandem mass
2D spectrometry [1]; SPOT 821: Peptide mass fingerprinting [1]; SPOT 821:
2D Tandem mass spectrometry [1]; SPOT 845: Peptide mass fingerprinting [1];
2D SPOT 845: Tandem mass spectrometry [1]; SPOT 846: Peptide mass
2D fingerprinting [1]; SPOT 846: Tandem mass spectrometry [1]; SPOT 1003:
2D Peptide mass fingerprinting [1]; SPOT 1003: Tandem mass spectrometry [1];
2D SPOT 1066: Peptide mass fingerprinting [1]; SPOT 1066: Tandem mass
2D spectrometry [1]; SPOT 1076: Peptide mass fingerprinting [1]; SPOT 1076:
2D Tandem mass spectrometry [1]; SPOT 1078: Peptide mass fingerprinting [1];
2D SPOT 1078: Tandem mass spectrometry [1]; SPOT 1116: Peptide mass
2D fingerprinting [1]; SPOT 1116: Tandem mass spectrometry [1].
CC ---------------------------------------------------------------------------
CC Data from Dr. Willard Freeman, Penn State College of Medicine, USA
CC ---------------------------------------------------------------------------
DR UniProtKB/Swiss-Prot; P63261; ACTG_HUMAN.
//
The following 2-D map is available for this protein:
|
Rat hippocampal synaptoproteome
|
---|
World-2DPAGE Repository (search AC)
|